Intracerebral hirudin injection alleviates cognitive impairment and oxidative stress and promotes hippocampal neurogenesis in rats subjected to cerebral ischemia
Research article published in Neuropathology : official journal of the Japanese Society of Neuropathology (2023)
Abstract
Cerebral ischemia starts with cerebral blood flow interruption that causes severely limited oxygen and glucose supply, eliciting a cascade of pathological events, such as excitotoxicity, oxidative stress, calcium dysregulation, and inflammatory response, which could ultimately result in neuronal death. Hirudin has beneficial effects in ischemic stroke and possesses antioxidant and anti-inflammatory properties. Therefore, we investigated the biological functions of hirudin and its related mechanisms in cerebral ischemia. The ischemia-like conditions were induced by transient middle cerebral artery occlusion (MCAO). To investigate hirudin roles, intracerebroventricular injection of 10 U hirudin was given to the rats. Cognitive and motor functions were examined by beam walking and Morris water maze tests. 2,3,5-triphenyl tetrazolium chloride-stained brain sections were used to measure infarct volume. Oxidative stress was determined by assessment of oxidative stress markers. The proliferated cells were labeled by BrdU and Nestin double staining. Western blotting was performed to measure protein levels. Hirudin administration improved cognitive and motor deficits post-ischemia. Hirudin reduced brain infarction and neurological damage in MCAO-subjected rats. Hirudin alleviated oxidative stress and enhanced neurogenesis in ischemic rats. Hirudin facilitated the promotion of phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and serine-threonine kinase. In sum, hirudin alleviates cognitive deficits by attenuating oxidative stress and promoting hippocampal neurogenesis through the regulation of ERK1/2 and serine-threonine kinase in MCAO-subjected rats.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Cerebral ischemia starts with cerebral blood flow interruption that causes severely limited oxygen and glucose supply, eliciting a cascade of pathological events, such as excitotoxicity, oxidative stress, calcium dysregulation, and inflammatory response, which could ultimately result in neuronal death.
Warum dies für die Hirudotherapie relevant ist
Diese Studie untersuchte, ob eine intrazerebroventrikuläre Hirudin-Injektion (10 U) die kognitive und motorische Funktion verbessern, das Hirninfarktvolumen reduzieren, oxidativen Stress abmildern und die hippocampale Neurogenese bei Ratten fördern könnte, die einem transienten Verschluss der Arteria cerebri media (MCAO) unterzogen wurden. Da Hirudin das bioaktive Antikoagulans ist, das am engsten mit medizinischen Blutegeln und der Hirudotherapie verbunden ist, sind seine nachgewiesenen neuroprotektiven und neurogenen Effekte in einem Schlaganfallmodell von konzeptionellem Interesse für den ASH-Bereich. Das Abstract berichtet, dass Hirudin die Verhaltensergebnisse verbesserte, die Infarktgröße reduzierte, den oxidativen Stress linderte und die Neurogenese über ERK1/2- und Serin-Threonin-Kinase-Phosphorylierung verstärkte. Es handelt sich jedoch um eine präklinische Tierstudie unter Verwendung direkter Hirninjektion von gereinigtem Hirudin – sie umfasste keine Blutegel und keine Blutegeltherapie, und ihre Relevanz für die klinische Hirudotherapie ist indirekt und begrenzt.
Zitation
Intracerebral hirudin injection alleviates cognitive impairment and oxidative stress and promotes hippocampal neurogenesis in rats subjected to cerebral ischemia.
Xia X et al. · Neuropathology : official journal of the Japanese Society of Neuropathology, 2023
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: March 18, 2026 · Letzte Aktualisierung der Website: June 18, 2026